Vivos Therapeutics Inc — Quarterly Cash Flow (NASDAQ:VVOS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 15.28 M11.28 M26.03 M25.64 M25.15 M Total liabilities 7.33 M6.88 M21.45 M23.11 M26.7 M Total equity 7.95 M4.41 M4.58 M2.53 M-1.55 M Total liabilities & shareholders' equities 15.28 M11.28 M26.03 M25.64 M25.15 M Total debt ——7.97 M8.77 M8.88 M Net debt ——3.36 M5.29 M6.85 M

News

Vivos Therapeutics, Inc. (VVOS) Q4 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates

Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates

Health Catalyst (HCAT) Lags Q4 Earnings Estimates

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivos Therapeutics (NASDAQ:VVOS)

Vivos Therapeutics announces $4.64 million warrant exercise deal

Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know

Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript

Vivos opens new sleep center in Michigan, expanding national footprint

Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript

Earnings call transcript: Vivos Therapeutics Q3 2025 shows revenue growth